Common rules for HTA

A decades’ long discussion in the EU about how to establish common rules for assessing the value of new medicines has come to a conclusion with a proposal from the European Commission on 31 January to regulate health technology assessment (HTA).

Full text available to subscribers only. Click here for information on subscribing to MedNous.